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STANDARDIZATION OF OCT ANGIOGRAPHY NOMENCLATURE IN RETINAL VASCULAR 
DISEASES: FIRST SURVEY RESULTS
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University Еуе Clinic, Bern, Switzerland
Abstract. Purpose. To develop a consensus nomenclature for OCT angiography (OCTA) findings in retinal vascular diseases. 
Design. Online survey using the Delphi Method. Participants. Members of The Retina Society, the European Society of Retina 
Specialists, and the Japanese Retina and Vitreous Society. Methods. An online questionnaire on OCTA terminology in retinal 
vascular diseases was sent to members of The Retina Society, the European Society of Retina Specialists, and the Japanese 
Retina and Vitreous Society. The respondents were divided into 2 groups (“experts” vs. “users”) according to the number of their 
publications in this field. The respondents who had more than 5 publications in the field of OCTA and retinal vascular diseases 
were considered the OCTA “experts” group. Main Outcome Measures Consensus and near consensus on OCTA nomenclature. 
Results. The complete responses of 85 retina specialists were included in the analysis. Thirty-one were categorized as 
“experts.” There was a consensus in both groups that OCTA parameters such as foveal avascular zone (FAZ) parameters, areas 
of nonperfusion, and presence of neovascularization (NV) should be implemented in the identification and staging of diabetic 
retinopathy (DR) and that OCTA can be applied to differentiate between ischemic and nonischemic retinal vein occlusion (RVO). 
Diabetic macular ischemia (DMI) also can be assessed via OCTA. Further, there was consensus that the terminology should 
differ on the basis of the underlying causes of decreased vascular flow signal. There was disagreement in other areas, such as 
which terms should be applied to describe decreased OCTA signal from different causes, the definition of wide-field OCTA, and 
how to quantify DMI and area of decreased flow signal. These discrepancies form the basis for the upcoming expert Delphi 
rounds that aim to develop a standardized OCTA nomenclature. Conclusions. Although there was agreement in some areas, 
significant differences were found in many areas of OCTA terminology among all respondents, but also between the expert and 
user groups. This indicates the need for standardization of the nomenclature among all specialists in the field of retinal vascular 
diseases.
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СТАНДАРТИЗАЦИЯ НА ОСТ-А НОМЕНКЛАТУРАТА ПРИ СЪДОВИ ЗАБОЛЯВАНИЯ НА 
РЕТИНАТА – ПЪРВИ РЕЗУЛТАТИ
М. Мунк, А. Кашани
Университетска очна клиника, Берн, Швецария
Резюме. Цел. Да се разработи консенсусна номенклатура за обективна диагностика на ОСТ ангиография (ОСТА) при 
съдови заболявания на ретината. Проект – онлайн проучване, използвайки метода Delphi. Участници. Членове на 
Ретиналното общество, Европейското дружество на специалистите по ретина и Японското общество на ретината и 
стъкловидното тяло. Методи. Онлайн въпросник за терминологията на OCTA при съдови заболявания на ретината 
беше изпратен на членовете на Ретиналното общество, Европейското дружество на специалистите по ретина и Япон-
ското общество на ретината и стъкловидното тяло. Участниците бяха разделени на 2 групи („експерти“ срещу „потре-
бители“) според броя на техните публикации в тази област. Участниците, които са имали повече от 5 публикации в 
областта на OCTA и съдовите заболявания на ретината, се считат за групата „експерти“ на OCTA. Основни крайни цели 
– Консенсус и почти консенсус относно номенклатурата на OCTA. Резултати. Пълните отговори на 85 специалисти по 
ретината бяха точно анализирани. Тридесет и един бяха категоризирани като „експерти“. Имаше консенсус и в двете 
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OCT angiography (OCTA) has become an es-
sential imaging modality in the diagnosis and fol-
low-up of retinal vascular diseases. OCTA gener-
ates 3-dimensional depth-resolved images of ret-
inal and choroidal vasculature [1, 2]. This nascent 
technology is fast, dye-free, and noninvasive, and 
can provide transverse and en face images to de-
tect and localize vascular flow abnormalities and 
to present structural and perfusion information 
all at once. OCTA can detect blood flow in the su-
perficial, middle, and deep retinal capillary plex-
us, as well as in the choriocapillaris and choroid.
OCTA provides a tool by which we can expand 
our understanding of retinal vascular diseases. 
In many cases, OCTA has already advanced our 
appreciation of clinical and physiologic phenom-
ena that were not previously known or detect-
able. However, there is no consensus to date on 
the OCTA terminology, and there are numerous, 
disparate, and often contradictory terms used to 
describe OCTA findings in the literature. For ex-
ample, Dodo et al3 used “flow void” to describe 
the absence of retinal and choroidal capillary 
flow signal in eyes with diabetic retinopathy (DR) 
on OCTA scans, whereas Nesper et al. [4] and Tian 
et al. [5] used the term “capillary nonperfusion.” 
Kashani et al [6, 7] and Kim et al. [8]used the 
term “impaired capillary perfusion” to indicate 
the possibility of altered perfusion without com-
plete absence of perfusion. Other terms such as 
“grayish areas,” “no-flow areas,” and “areas with 
decreased vascular perfusion” have been seen 
in publications [9, 10]. Additional terms such 
as “flow deficit,” “flow attenuation,” “low and no 
flow,” “reduced flow,” “flow abnormalities,” and 
“flow void” are interchangeably used in current 
literature [9, 10, 11, 12]. The underlying causes of 
flow attenuation should be considered when us-
ing these various terms. Flow signal attenuation 
due to ischemia and capillary dropout should be 
differently termed than flow attenuation because 
of the presence of macular edema and displace-
ment of retinal vessels, respectively. Slow, nonde-
tectable flow present in microaneurysms should 
be differentiated as well. Terms to quantify de-
creased vascular flow on OCTA are also hetero-
geneously used and assessed. “Intercapillary re-
gions,” “flow density,” “perfusion density,” “vessel 
density,” and “capillary dropout density” are in-
terchangeably applied in recent articles, and defi-
nitions are inconsistent. 
Nomenclature describing quantification of 
these various OCTA-based capillary nonperfu-
sion measures are also confusing. For example, 
perfusion density was defined as the percentage 
area occupied by perfused binarized vessels in 
some publications, whereas the same measure-
ment was defined in some other studies as vessel 
density [10]. The manufacturer software of Zeiss 
Angioplex uses the term “vessel density” to quan-
tify the total length of skeletonized perfused vas-
culature per unit area in a region of measure-
ment (unit: U/mm), whereas Optovue uses the 
term “vessel density” to describe the total area 
of perfused vasculature per unit area in a region 
of measurement (unit: %). In contrast, the Zeiss 
software uses the term “perfusion density” to de-
scribe the latter assessment.
In addition to this inconsistency, OCTA manu-
facturer software does not allow the homogenous 
групи, че параметрите на OCTA, като параметрите на фовeалната аваскуларна зона (FAZ), зоните на неперфузия и на-
личието на неоваскуларизация (NV) трябва да бъдат приложени при идентифицирането и поставянето на диагнозата 
диабетна ретинопатия (DR) и че OCTA може да се прилага за разграничаване на исхемична и неисхемична оклузия 
на ретиналната вена (RVO). Диабетната макулна исхемия (DMI) също може да бъде оценена чрез OCTA. Освен това 
имаше консенсус, че терминологията трябва да се различава в зависимост от основните причини за намален сигнал в 
съдовия поток. Имаше разногласия в други области, като например кои термини трябва да се прилагат за описване на 
намален OCTA сигнал от различни причини, дефиницията на OCTA с широко поле и как да се определи количествено 
DMI и площта на сигнала с намален поток. Тези несъответствия формират основата за разработването на стандарти-
зирана OCTA номенклатура. Изводи. Въпреки че имаше съгласие в някои области, бяха открити значителни различия 
в много области на терминологията на OCTA сред всички участници, но също и между експертните и потребителските 
групи. Това показва необходимостта от стандартизация на номенклатурата сред всички специалисти в областта на 
съдовите заболявания на ретината.
Ключови думи: ОСТ ангиография, съдово заболяване на ретината, диабетна ретинопатия, оклузия на ретиналната 
вена, Delphi
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assessment of 1 single quantitative OCTA param-
eter across different machines. Although Zeiss 
Angioplex offers the analysis of perfusion den-
sity, vessel density, and different foveal avascular 
zone (FAZ) parameters such as circularity, size, 
and area, Optovue enables the assessment of the 
vessel density, flow, and nonflow area assessment 
and different FAZ parameters such as FAZ area, 
perimeter, and AI/FD (circularity index/FD-300 
[vessel density 300 μm from the fovea]). Other 
commercial software only allows the manual as-
sessment of the FAZ area so far.
Until now, the FAZ area is the most consistently 
assessable parameter across al. OCTA software. 
However, some devices allow FAZ area assess-
ment only in the superficial slab, whereas others 
enable assessment only in the whole retina slab. 
This inhomogeneity leads to the use of nonvali-
dated third-party software such as Image J. In ad-
dition, various parameters must be manually ad-
justed for each software version, such as thresh-
old, contrast, sharpening, color balance, and 
denoising, which makes the comparison among 
different studies and assessments unreliable.
Variable segmentation strategies of the su-
perficial and deep capillary plexus add to the 
heterogeneity. Although some algorithms use the 
middle of the inner nuclear layer as the bound-
ary (e.g., Optovue), others use the top of the inner 
nuclear layer (e.g., Topcon) [6].
All these issues make the homogenous de-
scription and collection of OCTA data impossible. 
Consensus terminology would not only help sim-
plify and consolidate these terms but also im-
prove accuracy of the measurements and quan-
tification.
It is our aim to establish a consensus nomen-
clature for OCTA findings in the field of retinal 
vascular diseases. This article describes the first 
step to develop the latter using a Delphi Method 
and presents the consensus results of an elec-
tronic survey carried out among the members 
of the Japanese Retina and Vitreous Society, The 
Retina Society, and the European Society of Reti-
na Specialists. It will be followed by expert Delphi 
rounds, which aim to reach consensus for param-
eters and questions in which no initial majority 
agreement could be reached.
Methods
We conducted a literature search via PubMed 
database for articles written in English in the 
field of retinal vascular diseases and OCTA. We 
comprehensively reviewed the literature to ex-
plore and collect all commonly used terms to 
describe OCTA blood flow information in the en 
face OCTA and cross-sectional OCTA B-scans. This 
was the basis of an electronic survey consisting 
of 33 questions and 5 main categories. This sur-
vey was compiled via an online platform (Sur-
vey Monkey) and included general questions on 
OCTA and wide-field OCTA imaging, OCTA termi-
nology of vascular flow alterations, terminology 
for retinal neovascularization (NV), the use of 
OCTA in retinal vascular diseases management 
and artifacts terminology in en face OCTA, and 
cross-sectional OCTA B-scans [28]. The complete 
survey is shown in Table S1 (available at www.
ophthalmologyretina.org). Institutional Review 
Board was not required. All research adhered 
to the tenets of the Declaration of Helsinki. All 
participants provided informed consent.
The questionnaire was sent to members of 
The Retina Society, the European Society of Ret-
ina Specialists, and the Japanese Retina and Vit-
reous Society from May to August 2020 via an 
online link. Personal information could be pro-
vided, but there was also the option to remain 
anonymous. All attendees were asked to indicate 
the number of publications in the field of retinal 
vascular diseases and OCTA, and an estimate of 
OCTAs they are usually evaluating in the clinic 
per week. Based on their expertise, respondents 
were divided into 2 groups: “user” and “expert” 
groups.8 The expert group was defined by 5 or 
more publications in this field, and the remaining 
participants were categorized as “OCTA users” 
[8].
To start, the guidelines for wide-field imaging 
of the International Wide-field Imaging Study 
Group were used for defining the wide-field im-
aging in OCTA [29]. As a basis for defining retinal 
NV, the recommended, mutually agreed defini-
tions of (neovascularization elsewhere [NVE]/
neovascularization at the disc [NVD]) on the 
cross-section and OCTA en face scans were use.
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To describe and define OCTA artifacts, the 
following terms were used, all regularly used in 
respective literature and by experts: 
 • Motion artifact: image artifact caused by eye 
movement during image acquisition
 • Projection artifact: the artificial appearance 
of flow in deeper retinal layers
 • Segmentation artifact: artifact caused from 
improper segmentation by software after image 
acquisition has been completed
 • Blink artifact: artifact caused by the patient 
blinking during imaging
 • Shadowing artifact: artifacts caused by 
media opacity or hemorrhage during imaging that 
appears as areas of decreased flow information on 
the structural en face and the en face OCTA slabs.
Based on prior experience with the Delphi 
method, the general agreement within a group 
must be assessed [3]. Agreement threshold is 
usually set at 60%. Thus, consensus was defined 
by an agreement of ≥ 60% in this article. Near 
consensus was achieved in the case of 51% to 
60% agreement, and no consensus was defined 
by a < 51% agreement. The term “agreement” 
refers to the consensus among the members of 
the “users” group or the “experts” group.
Results
Overall, 164 retina specialists took part and 
88 specialists completed this online survey. Some 
96.6% (n = 85) of them owned an OCTA machine, 
and 3.4% (n = 3) did not and were also excluded 
from further analysis. Of these 85 participants, 
31 (26%) were considered experts with ≥ 5 
publications in the field.
OCTA Wide-field Imaging
A consensus among the users group (66.67%) 
was obtained that the current definition of wide-
field imaging (the visualization of all 4 vortex 
veins) cannot be transferred to OCTA in retinal 
vascular diseases. However, only 51.61% of the 
experts agreed on this.
Near consensus was achieved based on which 
parameter wide-field OCTA imaging should be 
used to designate. Some 58.33% of the users 
group versus 43.75 % of the experts group agreed 
that the degrees of field of view (FOV) should be 
the determining factor. There was near consensus 
among the experts group (57.14% vs. 42.86% of 
the users group) that an FOV of ≥ 120° should be 
considered as wide-field OCTA (Fig 1). 
Measurement of Decreased Vascular Flow 
on Conventional and Wide-field OCTA
Some 74.19% of the OCTA experts group thought 
that automatic measurement in square millimeters 
using manufacturer software should be the method 
of choice for the assessment of areas of decreased 
flow. An area of > 0.5 mm2 was proposed by 57.69% 
of the experts group (53.49% of the users group) to 
be considered as a “large area of decreased flow” on 
conventional OCTA (Fig 2).
Some 59.26% of the users group (51.61% of 
the experts group) thought that decreased flow on 
Fig. 1. Near consensus was achieved to define wide-field OCT angiography (OCTA) based on field of view (FOV). Montage OCTA of the 
posterior pole in a normal patient (superficial plexus scan) showing a 70° FOV (composite of 2 images of 15 × 9 mm) (A)  
and 90° of FOV (5 images of 12 × 12 mm) (B)
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wide-field OCTA should be measured by percen-
tage of decreased flow area and not by number 
of affected subfields. A consensus was reached 
among the experts group (62.5% vs. 50% of users 
group) that a large flow decrease should be de-
fined as ≥30% of the total wide-field area (Table 
1 and 2). Some 43.75% of the users group believed 
that it should be defined as ≥10% (Fig 2).
Terminology and Nomenclature of De-
creased Vascular Flow on Convention-
al and Wide-field OCTA
Most participants (83.53%) agreed that it 
would be necessary to distinguish the cause of re-
duced flow in retinal vascular diseases. They sug-
gested that, besides artifacts, reduced flow signal 
in retinal vascular disease may arise from (1) in-
adequate blood supply causing capillary nonper-
fusion and ischemia (users group: 94.44%; ex-
perts group: 90.32%); (2) blockage due to hem-
orrhage or hard exudates (users group: 50%; ex-
perts group: 70.97%); (3) displacement of vessels 
due to cystoid macular edema (CME, users group: 
61.11%; experts group: 67.74%) (Table 1); and 
(4) decreased or slow flow in microaneurysms 
(users group: 59.26%; experts group: 90.32%) 
(Table 1). However, there was no consensus on 
which terms should be specifically used.
Decreased flow signal of unknown origin: 
Some 21.18% of the respondents preferred the 
term “nondetectable flow signal” to describe a 
flow decrease of unknown origin, and 18.82% 
preferred the term “flow decrease.” There was 
no difference between the users group (20.37% 
and 20.37%, respectively) and the experts group 
(22.58% and 16.13%, respectively).
Decreased flow signal due to CME: Some 
16.67% of the participants preferred the term 
“nondetectable flow signal,” and 14.29% of the 
participants liked the suggested terms “flow at-
tenuation” and “flow void” to describe decrease 
in flow signal caused by vessel displacement in 
the presence of CME. Some 19.35% of the experts 
group chose the term “flow impairment.”
Decreased flow signal due to signal blockage: 
Some 41.94% of the experts group and 31.48% 
of the users group deemed the suggested term 
“nondetectable flow signal” as most suitable to 
describe decreased flow signal in the presence of 
hemorrhage or hard exudates. Some 25.81% of 
the experts group and 29.63% of the users group 
favored the term “signal void.”
Decreased flow signal due to slow flow: Pre-
ferred terms to describe flow decrease due to mi-
croaneurysms were “flow decrease” (27.78% of 
the users group) and “flow impairment” (25.81% 
of the experts group).
Fig. 2. Consensus was achieved on using the manufacturer’s software to measure areas of decreased retinal flow signal on traditional 
OCTA, and near consensus was reached on using the percentage of decreased flow area in wide-field OCT angiography (OCTA). A 3 
× 3-mm superficial plexus OCTA scan centered on the fovea (A) and a wide-field superficial retinal plexus OCTA scan (B) 90° of FOV 
showing areas of decreased retinal flow
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Table 1. Questions for which a Co-agreement Was Achieved between the “Users” Group and the OCTA “Experts” Group
Item No. Question
Survey Response OCTA Users 
Group (n = 54) (%)
Survey Response OCTA Experts 
Group (n = 31) (%)
8
Do you consider it necessary to distinguish 
cause of decreased vascular flow in retinal 
vascular diseases?
Yes 83.87% Yes 83.33%
9
Decreased vascular OCTA flow in diabetes 
can be secondary to
Ischemia 94.44%
Displacement of vessels 61.11%
Ischemia 90.32%
Displacement of vessels 67.74%
23
Do you think today OCTA should be 
implemented in identification and severity 
staging of DR?
Yes 72.22% Yes 83.87%
24
Parameters that should be used to identify 
and stage severity of DR
The presence of NV 84.62%
FAZ parameters 74.36%
Presence and amount of no flow 
areas 74.36%
The presence of NV 73.08%
FAZ parameters 69.23%
Presence and amount of no flow 
areas 76.92%
25
Do you think OCTA can be used in 
identification and staging of DMI?
Yes 88.89% Yes 93.55%
27
Should/can ischemic vs. nonischemic RVO 
be defined based on wide-field OCTA?
Yes 85.19% Yes 83.87%
DMI = diabetic macular ischemia; DR = diabetic retinopathy; FAZ = foveal avascular zone; NV = neovascularization; NVD = neo-
vascularization at the disc; OCTA = OCT angiography; RVO = retinal vein occlusion.





3 The International Wide-field Imaging Study Group definition of wide-field does not apply to OCTA (users group)
8 The necessity to distinguish cause of decreased vascular flow in retinal vascular diseases (both groups)
9 Causes of decreased vascular OCTA flow in retinal vascular diseases (both groups)
10
Automated inbuilt software shall be used to quantify and report the area of decreased vascular flow on OCTA 
(experts group)
16 If % is used, then ≥30% shall define an area of large flow decrease (experts group)
18
The necessity to apply different terms to describe OCTA vascular flow decrease due to different causes? (experts 
group)
23 OCTA should be implemented in the identification and severity staging of DR? (both groups)
24
Presence of NV and area of nonperfusion and FAZ parameters shall be implemented in identification and severity 
staging of DR (both groups)
25 OCTA can be used in identification and staging of DMI (both groups)
27 Ischemic vs. nonischemic RVO can be defined on the basis of wide-field OCTA (both groups)
32 The OCTA ILM/vitreous slab should be preferably used to detect NVE/NVD (experts group)
Near Consensus
4 Parameter, wide-field OCTA definition should be based on (users group)
6 The degrees of field of view (FOV) to define “wide-field OCTA” (experts group)
11
A large area of decreased flow on conventional OCTA should be >0.15 mm2, >0.3 mm2, or 0.5 mm2? (both 
groups)
14
The easiest way to quantify and report the size of decreased vascular flow on wide-field OCTA for peripheral flow 
decrease (both groups)
28 The parameter to define ischemic RVO based on wide-field OCTA (users group)
8
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Definition of NVE/NVD: There was consensus 
in the experts group (70.94%) that NVE or NVD 
should be described as “supraretinal flow with 
breaching of internal limiting membrane (ILM) on 
OCTA cross-section scan and as a dense, irregular 
and convoluted network of vessels visible on ILM-
vitreous and superficial slabs on en face OCTA” 
according to medical retinal consensus (Table 2). 
Some 57.41% of the users group believed that only 
the ILM/vitreous slab should be used to detect 
NVE/NVD, and 33.33% of them suggested using 
any slab that depicts the NV (Fig 3).
OCTA in Retinal Vascular Disease Man-
agement and Staging
Diabetic Retinopathy
The majority of respondents (76.47%) agreed 
that OCTA should be implemented in identifica-
tion and staging of severity of DR (Table 1).
There was consensus that the parameters “the 
presence of NV” (experts group: 73.08%; users 
group: 84.62%), “the FAZ parameters” (experts 
group: 69.23%; users group: 74.36%), and “the 
presence and amount of no flow areas” (experts 
group: 76.92%; users group: 74.36%) should be 
added for the staging and classification of DR. In 
addition, the users group also suggested that the 
presence of microaneurysms (64.1%), the num-
ber of intraretinal microvascular abnormalities 
(79.49%), and the vessel density in the superfi-
cial capillary plexus (61.54%) and the deep cap-
illary plexus (66.67%) seen on OCTA should be 
included to grade the severity of DR (Table 1).
Diabetic macular ischemia (DMI) is characte-
rized by the occlusion and loss of the macular 
capillary network. Almost all of the participants 
(90.59%) believe that OCTA is an indispensable 
modality for the staging of DMI (Table 1). Howev-
er, there was no agreement on the most suitable 
parameters: No consensus was reached among 
the participants. Some 38.96% chose “the FAZ 
size,” and 37.66% suggested “the perifoveal ves-
sel density” to define and quantify DMI (Table 2).
No Consensus
19 The term to describe flow decrease in SCP, DCP of unknown origin
20 The term to describe flow decrease in SCP, DCP due to vessels displacement by CME
21 The term to describe OCTA vascular flow decrease due to signal blockage/shadowing
22 The term to describe OCTA vascular flow decrease due to slow flow
26 The way to define and quantify DMI
30 The percentage of decrease flow area to define ischemic vs. nonischemic RVO in wide-field OCTA images
CME = cystoid macular edema; DCP = deep capillary plexus; DMI = diabetic macular ischemia; DR = diabetic retinopathy; FAZ 
= foveal avascular zone; ILM = internal limiting membrane; NVD = neovascularization at the disc; NVE = neovascularization 
elsewhere; OCTA = OCT angiography; RVO = retinal vein occlusion; SCP = superficial capillary plexus. Consensus was defined by 
an agreement of ≥ 60% in the experts group or the users group. Near consensus was defined by an agreement of 51% to 60% 
in the experts group or the users group. No consensus was defined by a < 51% agreement in both groups. The referring group 
is provided in parentheses
Fig. 3. Examples of retinal neovascularization (NV) visible on different OCT angiography (OCTA) slabs. A, OCTA internal limiting mem-
brane (ILM)/vitreous slab. B, OCTA superficial capillary plexus slab. C, OCTA whole retinal slab
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Retinal Vein Occlusion
Most of the participants (84.71%) agreed that 
ischemic versus nonischemic retinal vein occlusion 
(RVO) can be defined via wide-field OCTA. Some 
56.52% of the users group and 46.15% of the ex-
perts group preferred “percentage of decreased 
flow areas in the wide-field OCTA image compared 
to total area” to define ischemic versus nonischemic 
RVO. Furthermore, no consensus was achieved on 
what percentage should be used to define ischemic 
versus nonischemic RVO (Table 2). Some 50% of 
the experts group and 34.62% of the users group 
believed that the area of decreased flow on wide-
field OCTA should be ≥ 30% of absolute area to de-
fine ischemic RVO. Some 36.96% of the users group
and 30.77% of the experts group suggested “non-
flow or decreased flow area” based on optic nerve 
head (ONH) area equivalents as the most suitable 
parameter to assess ischemic versus nonischemic
RVO. Among them, 62.5% of the experts group rec-
ommended that ischemic RVO should be diagnosed 
in the presence of “≥ 10 ONH area equivalents.”
Artifacts
A consensus was reached in the experts 
group (68.97% to 100%, depending on individ-
ual proposed artifact terms) and the users group 
(52.94% to 94.12%) with respect to the descrip-
tion of OCTA artifacts. The terminology proposed 
by the medical retina community for normal reti-
na should be applied for retinal vascular diseases 
as well.
No Consensus
Important points for which no consensus was 
reached in the experts or the users group (Table 
2) included the parameter for defining wide-field 
OCTA, the term used to describe flow decrease 
caused by various causes, the simplest way to de-
fine and quantify DMI, and the way to define isch-
emic RVO based on wide-field OCTA.
Discussion
Based on the current OCTA terminology found 
in the literature, we created an online survey and 
distributed it among specialists in the field of reti-
nal vascular diseases. The purpose was to explore 
the application and use of the OCTA nomenclature, 
with the final goal to standardize OCTA nomencla-
ture in the field of retinal vascular diseases.
OCTA can image the vascular structures of 
the retina by capturing high-resolution 2-dimen-
sional images of different layers of the retina us-
ing low coherence interferometry. This makes the 
OCTA an essential tool for detecting and monitor-
ing abnormal flow in retinal vascular diseases [3, 
8]. OCTA is dye-free and therefore bypasses dye 
leakage that limits our ability to evaluate capil-
lary perfusion. With the help of OCTA, it is now 
possible to visualize vascular features in different 
retinal layers [5]. This makes OCTA an ideal ap-
proach for the assessment of various retinal vas-
cular diseases such as DR, RVO, and retinal artery 
occlusion. There is no doubt that the evaluation 
of the morphology and quantitative assessment 
of vascular changes can help us improve our un-
derstanding of the pathological and physiologic 
processes, determine the disease’s activity and 
severity, and provide appropriate treatment and 
management of retinal vascular diseases. As a 
result, various clinical studies and publications 
focus on OCTA findings for the assessment of 
the pathophysiology, prediction, diagnosis, sever-
ity, response to therapies, and follow-up of retinal 
vascular diseases [7, 8, 9, 10]. With an increas-
ing number of publications in this field, different 
OCTA parameters are implemented, and there is 
a growing divergence in the use of terms to de-
scribe qualitative and quantitative changes on 
OCTA.
Wide-field OCTA
Although conventional 3 × 3-mm and 6 × 6 
mm images produce high-resolution images al-
lowing accurate assessment of the macular capil-
laries and vasculature, images of 9 × 9 mm to 15 
× 15 mm allow the assessment of a larger retinal 
area but trade the wider FOV for resolution [41].
To assess the vasculature beyond the vascular 
arcades with OCTA using currently available de-
vices, montage methods are used, which stitch 
several individual OCTA images automatically 
together Prototypes capturing up to 100 degree 
FOV at once have been developed as well [3].
The term “wide-field” OCTA is heterogeneous-
ly used for a single 12 × 12 mm OCTA scan, 4 and 
montage scans consist of two 15 × 9-mm scans,4 
five 12×12-mm scans, 5 two 12 × 12-mm scans,6 
four 12 × 12-mm scans, five 6 × 10-mm scans, or 
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five 9 × 9-mm scans [2]. All of these images are 
capturing different FOVs. The term “ultra–wide-
field OCTA” was introduced to describe 100° OCTA 
images consisting of a 4 × 4 grid of 16 individual 
6 × 6-mm2 scans. A consensus was reached in 
the users group in our survey that OCTA cannot 
visualize the vortex veins, and the Classification 
and Guidelines for Wide-field Imaging cannot be 
applied to OCTA in retinal vascular diseases [9]. 
This is in line with the results of the standard-
ization approach in uveitic OCTA nomenclature 
Unfortunately, no consensus was achieved in our 
survey on which parameter the wide-field defi-
nition should be based; however, the parameter 
FOV was favored (near consensus). Field of view 
≥ 70 degrees was the mutually agreed area and 
parameter in our previous uveitis survey, which 
should define wide-field OCTA [8].
Measurement and Terms of Decreased 
Flow Signal
Different methods have been used to mea-
sure areas of decreased flow on OCTA in retinal 
vascular diseases. Tan et al. [14] used a custom 
MATLAB algorithm to calculate retinal perfusion 
density, capillary perfusion density, and capillary 
dropout density in DR using 12 × 12-mm OCTA 
scans. Seknazi et al. [40] used the AngioAnalyt-
ics software to binarize and calculate the rela-
tive density of flow as a percentage of the total 
area. They ordinally graded capillary dropout on 
OCTA slabs ranging from 0 to 8 (0 being no cap-
illary dropout, and 8 being extensive capillary 
dropout). Kim et al. [8] used a custom semiauto-
mated algorithm to assess skeleton density, ves-
sel density, fractal dimension, and vessel diam-
eter index. To convert OCTA into binary images, 
a 3-step method consisting of a global threshold, 
hessian filter, and adaptive threshold in MATLAB 
was used. These examples demonstrate the ne-
cessity of a standardized procedure in measuring 
areas of reduced flow on OCTA in retinal vascular 
disease. A consensus was obtained in our survey 
that the manufacturer software should be used to 
measure areas of decreased flow on OCTA, and a 
near consensus was reached that a large area of 
decreased flow should be defined by an area of 
≥ 0.5 mm2. This consensus comes with a couple 
of challenges and limitations because the manu-
facturer software solutions of the different OCTA 
modules only allow the assessment of arbitrary 
parameters. In addition, OCTA images beyond 6 
× 6 mm are usually not quantifiable at all. The 
FAZ area is so far the only parameter that can 
be assessed on all devices; however, the compa-
rability of FAZ measures is limited given the di-
vergent segmentation methods (and of course 
the different underlying methods generating the 
flow motion contrast images). A near consensus 
was achieved that the size and amount of de-
creased vascular flow on wide-field OCTA should 
be reported in percentage of decreased flow area 
compared with the whole area. The respondents 
agreed that ≥ 30% of the affected area should be 
considered a “large flow decrease” on wide-field 
OCTA. This measure was favored over the assess-
ment of affected subfields, which has been regu-
larly used in wide-field OCTA studies [9].
There was strong consensus that different 
terms should be applied to account for the dif-
ferent possible underlying causes of decreased 
flow signal. Possible underlying mechanisms 
were accepted to be decreased flow signal of un-
known origin, inadequate blood supply causing 
ischemia, blockage due to hemorrhage or hard 
exudates, displacement of vessels due to macu-
lar edema, and decreased/slow flow in micro-
vascular abnormalities such as microaneurysms. 
Various terms such as “grayish areas,” “no-flow 
areas,” “areas with decreased vascular perfusion,” 
“flow deficit,” “flow impairment,” “reduced flow,” 
“flow abnormalities,” and “flow void” have been 
noted in publications to describe OCTA signal at-
tenuation secondary to various mechanisms. It 
was previously also recommended not to use the 
term “nonperfusion,” because it is possible that in 
areas of absent flow signal, the blood flow is just 
below the threshold of detection.Unfortunately, 
there was not a single consensus on what terms 
should be preferably applied for the individual 
reasons of reduced OCTA signal.
Staging of Disease Severity
There was unanimous agreement in our sur-
vey between the experts group and the users 
group that OCTA imaging should be implemented 
in the identification and staging of the severity of 
DR. The FAZ parameters, the presence of NV vis-
ible on OCTA, and the presence and amount of no 
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flow areas should be integrated in a new staging 
system. This is in line with previous studies high-
lighting the strong correlation of FAZ parameters 
with the severity of DR.8, It indicates the strong 
need for an updated severity assessment including 
other image modalities such as wide-field imag-
ing, wide-field fluorescein angiography, and OCTA, 
and parameters such as ischemia and presence of 
capillary nonperfusion probably beyond the con-
ventional, gold standard Early Treatment Diabetic 
Retinopathy Study 7-field color fundus imaging.
Until now, the definition of ischemic RVO is 
disputable. The most used parameter in the lit-
erature has been the area of nonperfusion visible 
on fluorescein angiography, which was most fre-
quently measured by the ONH area equivalents. 
An equivalent of ≥ 10 ONH areas was frequently 
used; however, other thresholds ranging from ≥ 5 
to ≥ 30 were applied as well. There was consensus 
among the users that the differentiation of isch-
emic versus nonischemic RVO can be made on the 
basis of wide-field OCTA. However, there was only 
near consensus that the percentage of decreased 
flow areas in the wide-field OCTA image compared 
with total area should be used as an assessment 
parameter. Some 50% agreed that an area of ≥ 
30% would define ischemic RVO. Only approxi-
mately 35% of the users and experts suggested 
ONH equivalents as a suitable tool to differentiate 
these 2 conditions. The majority choosing this pa-
rameter agreed that ≥ 10 ONH equivalents of de-
creased/absent flow signal (as in many previous 
FA studies) would indicate an ischemic RVO.
Artifact Assessment
A consensus was reached in the expert group 
and the user group that the so far proposed ar-
tifact terminology by the medical retina commu-
nity for normal retina can and should be applied. 
The terms “motion, projection, segmentation, and 
shadowing artifacts” should be used to describe 
potential imaging errors. This is in line with the 
results of the uveitis nomenclature survey.
Conclusions
Our intention is to standardize the hetero-
geneously used OCTA nomenclature in retinal 
vascular diseases. The first step was this survey 
presented. A potential limitation of the survey 
may be that because of the anonymity, the infor-
mation provided by the respondents regarding 
the number of publications and therefore their 
status of expert versus users could not be veri-
fied. However, we also note that respondents had 
no obvious incentive to misrepresent their expe-
rience in such an anonymous survey. Encourag-
ingly, in some areas and topics, consensus could 
already be achieved. However, it also highlights 
many discrepancies and discordance among reti-
na specialists, OCTA users, and OCTA experts. Our 
first results have illustrated that further expert 
discussion is needed to establish a standardized 
terminology for the use of OCTA in retinal vascu-
lar diseases. These areas include (among others) 
the definition of wide-field OCTA, the terms used 
to describe flow decrease induced by various 
causes, the simplest way to define and quantify 
DMI, and the way to define ischemic RVO based 
on wide-field OCTA. The results further highlight 
the need for at least a few parameters that can be 
automatically and homogeneously assessed by all 
OCTA modules, similar to central macular thick-
ness or retinal volume on structural OCTs. Manu-
facturers should be obligated to implement soft-
ware that allows the homogenous assessment of 
respective parameters across all OCT machines. 
These results form the basis for the development 
of an appropriate nomenclature via a Delphi ap-
proach among a smaller expert group in OCTA 
and retinal vascular diseases, which is currently 
ongoing.
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